Evidence map›Paper›PMID 39801789›Full record

ArticleJIMD reports2025

Liver Transplant From a Deceased Donor With Cystinosis: A Case Report.

Raeda Taj, Kim Ng, Sanmati R Cuddapah, Elizabeth B Rand, Melissa Bleicher, Sandra Amaral, Maarouf A Hoteit, Rajendar K Reddy, Eyob Feyssa, Emma E Furth and 5 more

Abstract read
In one paragraph

Article in JIMD reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Raeda TajDepartment of Surgery, Transplant Division Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.ORCID https://orcid.org/0000-0003-0602-8015
Kim NgDivision of Human Genetics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA.
Sanmati R CuddapahDivision of Human Genetics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA.
Elizabeth B RandDepartment of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition Children's Hospital of Philadelphia Philadelphia Pennsylvania USA.
Melissa BleicherDivision of Nephrology, Department of Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Sandra AmaralDivision of Nephrology, The Children's Hospital of Philadelphia, Department of Pediatrics and Department of Biostatistics, Epidemiology and Informatics Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA.
Maarouf A HoteitDivision of Gastroenterology and Hepatology Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Rajendar K ReddyDivision of Gastroenterology and Hepatology Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Eyob FeyssaDivision of Gastroenterology and Hepatology Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Emma E FurthDepartment of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Kim M OlthoffDepartment of Surgery, Transplant Division Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Samir Abu-GazalaDepartment of Surgery, Transplant Division Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Matthew H LevineDepartment of Surgery, Transplant Division Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Frederick VyasDepartment of Surgery, Transplant Division Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.
Peter L AbtDepartment of Surgery, Transplant Division Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many inherited metabolic disorders (IMD) are associated with end-organ damage necessitating organ transplantation. Although utilization of deceased donors with history of IMD warrants caution, there may be circumstances under which such donors could be considered as suitable organ donor candidates. We present the first known report of liver transplantation from a deceased donor with cystinosis. The donor was a 20-year-old male with infantile cystinosis who had previously undergone two deceased donor kidney transplants. Unfortunately, he incurred cranial trauma, and after careful consideration of the metabolic consequences, his liver was deemed suitable for transplantation. The liver was successfully transplanted into a 65-year-old female recipient with hepatitis C (HCV) cirrhosis. The recipient is currently 12 months post-transplant and experiencing good graft function without evidence of cystine crystals on liver biopsy. This case highlights that liver transplantation from donors with rare IMD can result in favorable outcomes. However, it is crucial to approach the use of such livers with caution. These transplants should be considered after a thorough assessment, ensuring that a comprehensive decision-making process is in place to mitigate potential risks.

Indexed as

cystinosisinherited metabolic disordersliver transplant

Identifiers

PMID39801789
PMCPMC11717895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.